Capital Medical University Reports Findings in Liver Cancer (Nomogram built based on machine learning to predict recurrence in earlystage hepatocellular carcin oma patients treated with ablation)
Capital Medical University Reports Findings in Liver Cancer (Nomogram built based on machine learning to predict recurrence in earlystage hepatocellular carcin oma patients treated with ablation)
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Oncology - Liver Cancer is the subject of a report. According to news reporting from Beijing, People’s Republic of China, by NewsRx journalists, research stated, “To analyze the risk factors affecting recurrence in early-stage hepatocellular carcinoma (HCC) patients treated with ablation and then establish anomogram to provide a clear and accessible representation of the patients’ recurrence risk. Collect demographic and clinical data of 898 early-stage HCC patients who underwent ablation treatment at Beijing You’an Hospital, affiliated with Capital Medical University from January 2014 to December 2022.”
Key words
Beijing/People's Republic of China/Asia/Cancer/Carcinomas/Cyborgs/Emerging Technologies/Health and Medicine/Live r Cancer/Machine Learning/Oncology/Risk and Prevention
NETL
NSTL